Improving cancer therapy by doxorubicin and granulocyte colony-stimulating factor: Insights from a computerized model of human granulopoiesis

Mathematical Modelling of Natural Phenomena

Volumn 1, Issue 2, 2006, Pages 70-80

  Vainstein, V ^a   Ginosar, Y ^a   Shoham, M ^b   Ianovski, A ^b   Rabinovich, A ^b   Kogan, Y ^a   Selitser, V ^a   Agur, Z ^a,b  

^a Institute for Medical Biomathematics Isarel   (Israel)

^b Optimata Ltd   (Israel)

Author keywords

chemotherapy; granulopoiesis; mathematical modeling; treatment optimization

Indexed keywords

ACCURATE PREDICTION; CANCER CHEMOTHERAPY; CANCER PATIENTS; CANCER THERAPY; CLINICAL DATA; CLINICAL TRIAL; COMPUTER MODELS; DOSE LIMITING TOXICITY; DOXORUBICIN; GRANULOCYTE-COLONY STIMULATING FACTOR; GRANULOPOIESIS; HEALTHY INDIVIDUALS; MATHEMATICAL MODELING; NEUTROPENIA; OPTIMAL SCHEDULE; SIDE EFFECT; TREATMENT OPTIMIZATION;

BLOOD; CHEMOTHERAPY; DISEASE CONTROL; DISEASES; OPTIMIZATION; PATIENT TREATMENT;

PHYSIOLOGICAL MODELS;

EID: 79960783464     PISSN: 09735348     EISSN: 17606101     Source Type: Journal    
DOI: 10.1051/mmnp:2008003     Document Type: Article

References (0)